AU Patent

AU2001263251A1 — Method for treatment of tumors using nucleic acid ligands to pdgf

Assigned to Gilead Sciences Inc · Expires 2001-11-26 · 24y expired

What this patent protects

Patent listed against avacincaptad-pegol-sodium.

Drugs covered by this patent

avacincaptad-pegol-sodium (AVACINCAPTAD PEGOL SODIUM)

Patent Metadata

Patent number: AU2001263251A1
Jurisdiction: AU
Classification: —
Expires: 2001-11-26
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.